Skip to main content

Table 2 Interventions after PET/CT evaluation

From: FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma

Interventions No. of patients (%)
Single intervention 44   (44)
  Sunitinib   19  
  Sorafenib   20  
  IFN-α   4  
  Temsirolimus   1  
2 interventions 22   (22)
  TKI to mTORI   10  
  TKI to TKI   9  
  mTORI to TKI   3  
3 interventions 20   (20)
3 < interventions 15   (15)
TKI 96   (95)
mTORI 39   (39)
IFN-α 16   (16)
Metastasectomy 6   (6)
Nephrectomy 5   (5)
  1. Abbrebiations: IFN-α interferon-α, TKI tyrosine kinase inhibitor, mTORI mTOR inhibitor